Keros Therapeutics KROS Stock Technical Risk Signals Q4 2025 EPS Misses Views MAA MidAmerica tops first quarter 2026 EPS estimates by 31 percent as shares edge slightly higher Public Service Enterprise Group Inc PEG Bullish Brokerage Rating Actions Underscore Regulated Utility Growth Tailwinds Musk v OpenAI Trial Implications for AI Sector Governance Nonprofit Structure and PreIPO Valuation Illumina Inc ILMN Posts Robust Q1 2026 Earnings Beat Driven by Clinical Sequencing Strength and Surging NovaSeq X Demand Why is Erasca ERAS stock going down today Erasca posts 83 EPS beat no Q4 revenue reported Vanguard Energy Index Fund ETF Shares VDE A DataDriven Investment Merit Analysis for 2026 NCV Virtus flags ongoing interest rate volatility as key factor shaping latest quarterly results EQR Equity Q1 2026 EPS vastly outperforms estimates stock notches a small gain in todays trading What ITHAX ITHA revealed in previous earnings reports STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session EU Emergency Energy Measures Amid Iran Conflict Macroeconomic Spillover Southern Company SO Mixed Analyst Price Target Adjustments Amid Utility Sector Outperformance Launch of Independent Youth AI Safety Testing Benchmarking Regime